Muutke küpsiste eelistusi

Controversies in Stroke Care [Kõva köide]

Contributions by , Contributions by , Contributions by , Edited by , Contributions by , Contributions by , Contributions by , Contributions by , Edited by , Contributions by
  • Formaat: Hardback, 342 pages, kõrgus x laius x paksus: 247x165x23 mm, kaal: 853 g
  • Ilmumisaeg: 18-Jul-2013
  • Kirjastus: Byword Books
  • ISBN-10: 8181930894
  • ISBN-13: 9788181930897
Teised raamatud teemal:
  • Kõva köide
  • Hind: 107,01 €*
  • * saadame teile pakkumise kasutatud raamatule, mille hind võib erineda kodulehel olevast hinnast
  • See raamat on trükist otsas, kuid me saadame teile pakkumise kasutatud raamatule.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Lisa soovinimekirja
  • Formaat: Hardback, 342 pages, kõrgus x laius x paksus: 247x165x23 mm, kaal: 853 g
  • Ilmumisaeg: 18-Jul-2013
  • Kirjastus: Byword Books
  • ISBN-10: 8181930894
  • ISBN-13: 9788181930897
Teised raamatud teemal:
Stroke is the leading cause of neurological morbidity and mortality and the third leading cause of mortality worldwide. In spite of several advances over the past two decades in acute stroke management, stroke prevention and neuroprotection, there is no clear consensus in any of the areas of diagnosis and management. The complex interplay between treatment modalities and the individual patient makes each case quite unique and physicians need to walk the tightrope of balancing the subtle and complicated see-saw of evidence and experience-based medicine. This book has contributions by a group of internationally recognized experts who have written extensively on strategies of 'thinking out of the box while not discarding the current evidence'. The authors have taken their expertise and experience into account while formulating the best practice recommendations fully recognizing that guidelines fall short and there is a continued need to synthesize current best practice opinion with individualized medicine. This book offers a rational approach to the current diagnosis and treatment of stroke that individual physicians can apply to their practice.

Arvustused

"'Controversies in Stroke Care elegantly describes the issues behind the most compelling unresolved questions facing the stroke community.... [ It] essentially provides a roadmap to inform the priorities for research in the next decade.' (Karen L. Furie. Neurologist-in-Chief, Rhode Island Hospital, Professor and Chair of Neurology, Alpert School of Medicine at Brown University, USA)"

Foreword vii
Preface viii
Acknowledgements ix
Contributors x
Abbreviations xiii
1 Personalized Medicine-What Is It? Is It Worthwhile? Can It Be Continued In An Era Dominated By Managed Care And 'Evidence-Based Medicine'? 1(12)
Louis R. Caplan
2 Imaging The Ischaemic Penumbra: Ready For Prime Time In Clinical Trials And Practice 13(11)
Marc Fisher
3 Neuroprotection In Ischaemic Stroke 24(18)
Monica Saint
Ashfaq Shuaib
4 Thrornbolysis For Acute Ischaemic Stroke...Are Off-Label Indications Justified? 42(13)
M.V. Padma Srivastava
5 Antihypertensive Medications In Stroke: Controversies And Recommendations 55(22)
M.V. Padma Srivastava
Majaz Moonis
6 Intra-Arterial Interventions Within The 3-Hour Window After Acute Ischaemic Stroke 77(8)
Majaz Moonis
7 Controversies In The Management Of Intracerebral Haemorrhage 85(10)
Magdy Selim
8 Do All Stroke Patients Need To Be Evaluated For CAD? 95(11)
Rohit Bhatia
Abhishek Singh
9 Acute High-Dose Statins Improve Stroke Outcome: Myth Or Reality? 106(9)
Nils Henninger
10 Cervicocerebral Arterial Dissections 115(11)
Monica Saini
Ashfaq Shuaib
11 Prevention Of Deep Vein Thrombosis In Patients With Acute Stroke 126(9)
Jeyaraj D. Pandian
12 Antiepileptic Drug Prophylaxis For Seizures In Cerebrovascular Accidents 135(5)
Jayashree T. Narayanan
13 Antiplatelet Drugs: Does It Make A Difference Which One You Use? 140(18)
Fernando D. Testai
Philip B. Gorelick
14 Cerebral Venous Thrombosis 158(12)
Rohit Bhatia
15 Non-Convulsive Status And EEG Monitoring In The Neuro-ICU 170(7)
Jaishree T. Narayanan
16 Evaluation For Hypercoagulable States: Special Reference To Venous And Arterial Thrombosis 177(15)
M.V. Padma Srivastava
17 Role Of Infections In Stroke: How True Is The Association? 192(15)
Subhash Kaul
V.C.S. Srinivasarao Bandaru
18 Relationship Between Migraine And Stroke: How True And How Close? 207(7)
M.V. Padma Srivastava
19 Prevention Of Ischaemic Stroke: Carotid Revascularization 214(10)
Kumar Rajamani
Seemant Chaturvedi
20 Are Alzheimer Dementia (AD) And Vascular Dementia (VAD), Different Clinical Profiles Of The Same Disease Spectrum?: Defining The Common Markers 224(10)
M.V. Padma Srivastava
21 Restorative Therapy In Stroke: Is There A Role For Stem Cells? 234(25)
M.V. Padma Srivastava
Ashi Bhasin
22 Controversies In Telemedicine 259(14)
Pratik Bhattacharya
Ramesh Madhavan
23 Stroke In The Young: Does The Aetiology And Prognosis Differ From Stroke In Older Patients? 273(43)
Man Mohan Mehndiratta
Tarun Vijay
Prachi Mehndiratta
24 Obstructive Sleep Apnoea And Stroke 316(7)
Mamta Bhushan Singh
Index 323
Majaz Moonis MRCP, MD (Medicine), DM (Neurology), FRCP (Edin.) MRCP(I), FAAN, FAHA is Professor of Neurology at the University of Massachusetts Medical School and the Director of the Stroke Program and Services including the Vascular Neurology Fellowship Program, Massachusetts, USA. M.V. Padma Srivastava MD, DM (Neurology), FAMS is Professor of Neurology at the All India Institute of Medical Sciences, New Delhi, India.